NCT00239161终止4 期
TREATMENT OF ACUTE UNCOMPLICATED PYELONEPHRITIS WITH SHORT COURSE LEVOFLOXACIN A Pilot Study
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 终止
- 入组人数
- 30
- 试验地点
- 4
- 主要终点
- Microbiological cure at the 10-14 day and 33-35 day followup
研究概览
简要总结
The purpose of the study is to compare the safety and effectiveness of the antibiotic levofloxacin by administering a higher dose of levofloxacin using a shorter course of therapy to treat patients with infections of their kidney.
详细描述
The goal is to complete a pilot study of short course (5 days), high dose, levofloxacin treatment for women with acute uncomplicated pyelonephritis. Specific study objectives include:
- To assess the efficacy and tolerability of levofloxacin 750 mg once daily for treatment of acute uncomplicated pyelonephritis in 25 women.
- To describe the population pharmacokinetics of levofloxacin 750 mg once daily in treatment of young women with acute pyelonephritis.
- To identify urine proteins associated with the inflammatory response of acute pyelonephritis, and characterize the time course of resolution of these proteins following initiation of treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Recent onset (less than 7 days) of costovertebral angle pain or tenderness with or without fever, and with or without lower urinary tract symptoms (dysuria, frequency, urgency). Diabetic women without long term complications of diabetes (retinopathy, nephropathy, or neuropathy) may be enrolled.
- •Stable hemodynamic status and able to tolerate oral medication.
- •Pretherapy urine culture >107 cfu/L (>104 cfu/ml) of a uropathogen (E. coli, other Enterobacteriaceae, S. saprophyticus). Patients will be enrolled into the study prior to urine culture results being known. If pretherapy cultures are subsequently not positive (usually at 48 hours), subjects will be discontinued.
- •Pyuria (> 10 wbc/mm3 or > 10 X106 wbc/L by hemocytometer; > 6-10 wbc/hpf, or > 1+ LE (leukocyte esterase) dipstick).
排除标准
- •·Pregnancy, breastfeeding, fluoroquinolone allergy, and any underlying structural or functional genitourinary abnormality.
结局指标
主要结局
Microbiological cure at the 10-14 day and 33-35 day followup
次要结局
- Clinical outcome at each visit. Microbiologic outcomes at 24,48,and72 hrs, adverse antimicrobial effects, adverse events or antimicrobial resistance. Correlation between pharmacodynamic parameters, bacteriologic and clinical resolution will be analyzed.
研究者
研究点 (4)
Loading locations...
相似试验
终止
4 期
Urinary Tract Infection Study With the Antibiotic Levofloxacin Given at a Higher Dose Over a Shorter Period of TimeComplicated Urinary InfectionNCT00245791University of Manitoba30
Unknown
2 期
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)MalignancyAllogeneic Stem Cell TransplantationNCT00215007Charite University, Berlin, Germany
已完成
不适用
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adultsJPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300
已完成
不适用
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infectionJPRN-UMIN000015375Severance Hospital, Yonsei University200
招募中
不适用
Safety and Efficacy of Levofloxacin for Acute Ischemic StrokeAcute Ischemic StrokeNCT05799326Yi Yang100